Literature DB >> 2751429

Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.

V Jestin1, M Cherbonnel, M Morin, M Guittet, G Bennejean.   

Abstract

Eight monoclonal antibodies against the Ploufragan strain of Newcastle disease virus were used to characterize 58 virus strains including 29 French isolates. By combining ELISA and haemagglutination inhibition tests, PMV 1 strains were differentiated from other avian PMV 1 and grouped into 7 classes.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2751429     DOI： 10.1007/bf01311356

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  23 in total

1.  Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes.

Authors:  G Meulemans; M Gonze; M C Carlier; P Petit; A Burny
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  An ELISA blocking test using a peroxidase-labelled anti-HN monoclonal antibody for the specific titration of antibodies to avian paramyxovirus type 1 (PMV1).

Authors:  V Jestin; M Cherbonnel; R L'Hospitalier; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies.

Authors:  G Abenes; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Biological activities of monoclonal antibodies to the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus.

Authors:  G B Abenes; H Kida; R Yanagawa
Journal:  Nihon Juigaku Zasshi       Date:  1986-04

5.  The characterization of monoclonal antibodies to Newcastle disease virus.

Authors:  P H Russell; P C Griffiths; K K Goswami; D J Alexander; M J Cannon; W C Russell
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

6.  Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies.

Authors:  P H Russell; D J Alexander
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 7.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

8.  Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites.

Authors:  R M Iorio; M A Bratt
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

9.  Monoclonal antibodies against a paramyxovirus isolated from Japanese Sparrow-Hawks.

Authors:  S Hoshi; T Mikami; K Nagata; M Onuma; H Izawa
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103
View more
  4 in total

1.  An ELISA blocking test using a peroxidase-labelled anti-HN monoclonal antibody for the specific titration of antibodies to avian paramyxovirus type 1 (PMV1).

Authors:  V Jestin; M Cherbonnel; R L'Hospitalier; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Detection of Newcastle disease virus RNA in infected allantoic fluids by in vitro enzymatic amplification (PCR).

Authors:  V Jestin; A Jestin
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Evaluation of the molecular basis of pathogenicity of the variant Newcastle disease viruses termed "pigeon PMV-1 viruses".

Authors:  M S Collins; I Strong; D J Alexander
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Molecular characterisation of three avian paramyxovirus type 1 isolated from pigeons in France.

Authors:  Cyril Barbezange; Véronique Jestin
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.